Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | carnitine palmitoyltransferase 1A (liver) | Starlite/ChEMBL | No references |
Homo sapiens | carnitine palmitoyltransferase 1B (muscle) | Starlite/ChEMBL | No references |
Rattus norvegicus | Carnitine palmitoyltransferase 1A | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Onchocerca volvulus | Carnitine palmitoyltransferase 1A | 773 aa | 758 aa | 43.8 % | |
Trypanosoma cruzi | choline/carnitine O-acetyltransferase, putative | carnitine palmitoyltransferase 1B (muscle) | 738 aa | 617 aa | 28.0 % |
Candida albicans | similar to S. cerevisiae YAT2 putative carnitine O-acetyltransferase | Carnitine palmitoyltransferase 1A | 773 aa | 645 aa | 25.6 % |
Candida albicans | similar to S. cerevisiae YAT2 putative carnitine O-acetyltransferase | Carnitine palmitoyltransferase 1A | 773 aa | 645 aa | 25.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Giardia lamblia | Dipeptidyl-peptidase I precursor | 0.0443 | 0.3302 | 0.5 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin B-like cysteine peptidase | 0.0275 | 0 | 0.5 |
Toxoplasma gondii | preprocathepsin c precursor, putative | 0.0443 | 0.3302 | 0.5 |
Schistosoma mansoni | dipeptidyl-peptidase I (C01 family) | 0.0443 | 0.3302 | 0.5 |
Plasmodium falciparum | dipeptidyl aminopeptidase 1 | 0.0443 | 0.3302 | 0.5 |
Plasmodium vivax | dipeptidyl aminopeptidase 2, putative | 0.0443 | 0.3302 | 0.5 |
Echinococcus multilocularis | carnitine O palmitoyltransferase 1, liver | 0.0376 | 0.1979 | 0.5 |
Leishmania major | choline/Carnitine o-acyltransferase-like protein | 0.0376 | 0.1979 | 0.5 |
Trypanosoma cruzi | choline/carnitine O-acyltransferase, putative | 0.0376 | 0.1979 | 0.5 |
Echinococcus granulosus | carnitine O palmitoyltransferase 1 liver | 0.0376 | 0.1979 | 0.5 |
Plasmodium falciparum | dipeptidyl aminopeptidase 2 | 0.0443 | 0.3302 | 0.5 |
Trypanosoma cruzi | choline/carnitine O-acyltransferase, putative | 0.0376 | 0.1979 | 0.5 |
Plasmodium vivax | dipeptidyl aminopeptidase 1, putative | 0.0443 | 0.3302 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0785 | 1 | 0.5 |
Toxoplasma gondii | cathepsin CPC1 | 0.0443 | 0.3302 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.3391 uM | SUPPLEMENTARY: Inhibition of Carnitine palmitoyltransferase 1, liver isoform | ChEMBL. | No reference |
IC50 (binding) | = 0.6864 uM | SUPPLEMENTARY | SUPPLEMENTARY. | No reference |
IC50 (binding) | = 1.3701 uM | SUPPLEMENTARY: Inhibition of Carnitine palmitoyltransferase 1, muscle isoform | ChEMBL. | No reference |
IC50 (binding) | > 100 uM | SUPPLEMENTARY: Inhibition of Carnitine palmitoyltransferase 2 | ChEMBL. | No reference |
IC50 (binding) | > 100 uM | SUPPLEMENTARY | SUPPLEMENTARY. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.